Clinical Trials Directory

Trials / Completed

CompletedNCT01214317

Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis

Study of Combinative Effect of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Patients With Aggressive Multiple Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effect of combinative induction therapy with mitoxantrone and plasmapheresis versus induction therapy with mitoxantrone alone in cases of aggressive multiple sclerosis

Conditions

Interventions

TypeNameDescription
PROCEDUREplasmapheresis3 courses of plasmapheresis are performed before mitoxantrone injection in first 3 months to investigate the efficacy of plasmapheresis in comparison with the other arm that are only treated with mitoxantrone

Timeline

Start date
2010-01-01
Primary completion
2012-01-01
Completion
2012-02-01
First posted
2010-10-05
Last updated
2020-09-16
Results posted
2020-09-16

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01214317. Inclusion in this directory is not an endorsement.

Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis (NCT01214317) · Clinical Trials Directory